These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2325588)

  • 21. HIV vaccine trial in Africa.
    Voelker R
    JAMA; 1999 Mar; 281(10):889. PubMed ID: 10084896
    [No Abstract]   [Full Text] [Related]  

  • 22. [A good HIV-vaccine is not enough].
    Hansen J; Nielsen JO
    Ugeskr Laeger; 1994 Dec; 156(51):7703-4. PubMed ID: 7839539
    [No Abstract]   [Full Text] [Related]  

  • 23. Vaccines against STDs: specific considerations?
    Wigzell H
    Scand J Infect Dis Suppl; 1990; 69():207-11. PubMed ID: 2263896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "HIV-peplotion vaccine"--a novel approach to protection against AIDS by transepithelial transport of viral peptides to Langerhans cells for long-term antiviral CTL response. (A review).
    Becker Y
    Acta Microbiol Immunol Hung; 1996; 43(1):1-17. PubMed ID: 8806938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A possible role for glycoprotein gpV in the pathogenesis of varicella-zoster virus.
    Kinchington PR; Ling P; Pensiero M; Gershon A; Hay J; Ruyechan WT
    Adv Exp Med Biol; 1990; 278():83-91. PubMed ID: 1963048
    [No Abstract]   [Full Text] [Related]  

  • 26. Routine immunization in HIV: helpful or harmful?
    Sax P; Singer M
    AIDS Clin Care; 1996 Feb; 8(2):11-3, 15. PubMed ID: 11363059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospects for a human immunodeficiency virus/AIDS vaccine.
    Murphy FA; Folks TM; Lairmore MD
    Dev Biol Stand; 1990; 72():3-15. PubMed ID: 1704324
    [No Abstract]   [Full Text] [Related]  

  • 28. Coreceptors: implications for HIV pathogenesis and therapy.
    Moore JP
    Science; 1997 Apr; 276(5309):51-2. PubMed ID: 9122710
    [No Abstract]   [Full Text] [Related]  

  • 29. Vaccine to prevent AIDS.
    Tyring S
    Res Initiat Treat Action; 1999 Jan; 5(1):9-10. PubMed ID: 11366234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Papillomavirus-like particle vaccines.
    Schiller JT; Lowy DR
    J Natl Cancer Inst Monogr; 2001; (28):50-4. PubMed ID: 11158207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Highly attenuated HIV type 2 recombinant poxviruses, but not HIV-2 recombinant Salmonella vaccines, induce long-lasting protection in rhesus macaques.
    Franchini G; Robert-Guroff M; Tartaglia J; Aggarwal A; Abimiku A; Benson J; Markham P; Limbach K; Hurteau G; Fullen J
    AIDS Res Hum Retroviruses; 1995 Aug; 11(8):909-20. PubMed ID: 7492438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dynamic development of the research on a vaccine and drugs against HIV].
    Lennholm B
    Lakartidningen; 1990 Oct; 87(44):3628-9. PubMed ID: 2233047
    [No Abstract]   [Full Text] [Related]  

  • 33. Funding support lacking in search for HIV vaccine.
    AIDS Alert; 1999 Jan; 14(1):5-7. PubMed ID: 11366091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [HIV and vaccines].
    Payen MC
    Acta Urol Belg; 1993; 61(1-2):607-14. PubMed ID: 8517278
    [No Abstract]   [Full Text] [Related]  

  • 35. Vaccinating HIV patients: focus on human papillomavirus and herpes zoster vaccines.
    Koenig HC; Garland JM; Weissman D; Mounzer K
    AIDS Rev; 2013; 15(2):77-86. PubMed ID: 23681435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Return to the basics might breathe life into HIV vaccine pipeline.
    Khamsi R
    Nat Med; 2008 May; 14(5):469. PubMed ID: 18463642
    [No Abstract]   [Full Text] [Related]  

  • 37. HIV fusion.
    Bristow CL
    Science; 1996 Sep; 273(5282):1642-3. PubMed ID: 8830405
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunization of children at risk of infection with human immunodeficiency virus.
    Moss WJ; Clements CJ; Halsey NA
    Bull World Health Organ; 2003; 81(1):61-70. PubMed ID: 12640478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and immunogenicity of the PFP vaccine against respiratory syncytial virus (RSV): the western blot assay aids in distinguishing immune responses of the PFP vaccine from RSV infection.
    Piedra PA; Glezen WP; Kasel JA; Welliver RC; Jewel AM; Rayford Y; Hogerman DA; Hildreth SW; Paradiso PR
    Vaccine; 1995 Aug; 13(12):1095-101. PubMed ID: 7491817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chemokine receptors and HIV infections].
    Ranki A; Krohn K
    Duodecim; 1997; 113(5):361-3. PubMed ID: 11370078
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.